Cargando…
A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
Accurate risk stratification for patients with stage II/III colon cancer is pivotal for postoperative treatment decisions. Here, we aimed to identify and validate a circRNA‐based signature that could improve postoperative prognostic stratification for these patients. In current retrospective analysi...
Autores principales: | Ju, Huai‐Qiang, Zhao, Qi, Wang, Feng, Lan, Ping, Wang, Zixian, Zuo, Zhi‐Xiang, Wu, Qi‐Nian, Fan, Xin‐Juan, Mo, Hai‐Yu, Chen, Li, Li, Ting, Ren, Chao, Wan, Xiang‐Bo, Chen, Gong, Li, Yu‐Hong, Jia, Wei‐Hua, Xu, Rui‐Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783650/ https://www.ncbi.nlm.nih.gov/pubmed/31475771 http://dx.doi.org/10.15252/emmm.201810168 |
Ejemplares similares
-
Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma
por: Sun, Xiang-Hong, et al.
Publicado: (2020) -
The role of circRNAs in cancers
por: Zhu, Ling-Ping, et al.
Publicado: (2017) -
Identifying daily changes in circRNAs and circRNA-associated-ceRNA networks in the rat pineal gland
por: Zheng, Yi, et al.
Publicado: (2021) -
CircRNA hsa_circ_0004585 as a potential biomarker for colorectal cancer
por: Tian, Jinhai, et al.
Publicado: (2019) -
Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy
por: Dong, Yu, et al.
Publicado: (2023)